A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT04634552 · RECRUITING
Trial details
- NCT number
- NCT04634552
- Sponsor
- Janssen Research & Development, LLC
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-01
- Primary completion
- 2027-06-30
- Enrollment
- 510
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.